---
title: "Branded and Biosimilar Ophthalmology"
ocid: "ocds-r6ebe6-0000791665"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000791665"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000791665.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000791665.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-11-24"
---

# Branded and Biosimilar Ophthalmology

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000791665

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000791665)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000791665.json)

## Summary

The Common Services Agency, better known as NHS National Services Scotland, is overseeing the procurement process titled "Branded and Biosimilar Ophthalmology." This tender is primarily focused on the healthcare industry, specifically targeting the supply of branded and biosimilar ophthalmology medicines to NHS Scotland. Located in Edinburgh, the procurement follows an open procedure and is currently at the tender stage. Key deadlines include the submission deadline on 5th September 2025, with the award phase beginning the same day. The contract covers deliveries across all entities under the National Health Service (Scotland) Act 1978 and any Integrated Joint Boards established according to Scottish legislation. The procurement is valued at approximately £146,579,216 GBP.

This tender presents significant opportunities for businesses, particularly those in the pharmaceutical industry specialising in ophthalmology products. Companies with expertise in manufacturing and distributing branded and biosimilar medicines can benefit greatly by participating. The framework consists of multiple lots, including single supplier frameworks for specific drugs like Aflibercept and Faricimab, as well as multi-supplier frameworks for others like Aflibercept Biosimilar and Ranibizumab. Businesses capable of adhering to strict quality and regulatory requirements, such as possessing a valid UK Marketing Authorisation and ISO 9001 certification, will have a competitive edge. Moreover, this tender includes community benefit provisions, encouraging suppliers to engage with NHS Scotland’s Community Benefits Gateway to foster local community development.

## Notice

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

### Lot Information

Aflibercept (Eylea(r))

Supply of Aflibercept (Eylea(r)) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Aflibercept Biosimilar

Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Ranibizumab vials and Pre-filled Syringes

Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Faricimab (Vabysmo(r))

Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV544192 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Nov 2025 |
| Submission deadline | 5 Sep 2025 |
| Future notice date | Not specified |
| Award date | 30 Oct 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £146,579,216 |
| Lots value | £146,579,217 |
| Awards value | Not specified |
| Contracts value | £20,671,084 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Unsuccessful |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 7 |
| Supplier names | BAYER; BIOGEN IDEC; CELLTRION HEALTHCARE UNITED KINGDOM; MD BIOLOGICS; MERCURY PHARMACEUTICALS; SANDOZ; TEVA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Nov 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV544192
- 6 Aug 2025 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536396

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536396
  Branded and Biosimilar Ophthalmology - Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV544192
  Branded and Biosimilar Ophthalmology - Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- http://www.publictendersscotland.publiccontractsscotland.gov.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000791665
- https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000791665. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000791665.json.